Structure and Physico-chemical Properties
|
Molecular properties generated using the CDK |
|||||||||||||||||||
Classification  |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (2011)) |
| Is prodrug? | Yes |
| Active form | azilsartan |
| IUPAC Name |
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-2H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate |
| International Nonproprietary Names |
|
| INN number | INN |
| 8874 | azilsartan medoxomil |
| Synonyms |
| Edarbi® |
| TAK 491 |
| Database Links |
|
| CAS Registry No. | 863031-21-4 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL2028661 |
| DrugBank Ligand | DB08822 |
| PubChem CID | 11238823 |
| Search Google for chemical match using the InChIKey | QJFSABGVXDWMIW-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | QJFSABGVXDWMIW |
| Search PubMed clinical trials | azilsartan medoxomil |
| Search PubMed titles | azilsartan medoxomil |
| Search PubMed titles/abstracts | azilsartan medoxomil |
| Wikipedia | Azilsartan |
| Comments |
| Azilsartan medoxomil is metabolised into the active form azilsartan. The azilsartan ligand page (accessed via the link above) contains more details of the drug's clinical use and mechanistic action. The marketed brand, Edarbi®, contains azilsartan medoxomil potassium (PubChem CID 23699544). |
